From Cell Division to Systemic Dysregulation: Genetic Mechanisms and Biomarkers in Civilization Diseases

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Cell Biology".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 1301

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, 128 Szaserów Street, 04-141 Warsaw, Poland
Interests: regulatory lymphocytes; cell biology; immunotoxicology; clinical immunology; neuroimmunology; flow cytometry

E-Mail Website
Guest Editor Assistant
Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, 128 Szaserów Street, 04-141 Warsaw, Poland
Interests: cell and molecular biology; neurobiology; blood–brain barrier; cancer biology; senescence

Special Issue Information

Dear Colleagues,

Cell division and genetic regulation are fundamental processes that sustain life and maintain tissue homeostasis. The dysregulation of these mechanisms underlies the pathogenesis of a wide range of human disorders, from cancer and neurodegeneration to infectious diseases and diseases of civilization such as diabetes, obesity, and cardiovascular conditions. Increasing evidence highlights the role of genetic and epigenetic alterations, cellular senescence, and molecular biomarkers in the development and progression of these diseases. Understanding these complex interactions at the cellular and systemic levels is crucial in the advancement of diagnostics, prognostics, and targeted therapies.

We are pleased to invite you to contribute to this Special Issue, “From Cell Division to Systemic Dysregulation: Genetic Mechanisms and Biomarkers in Civilization Diseases”. We aim to showcase novel insights into molecular and cellular mechanisms, as well as translational research highlighting their clinical impact.

This Special Issue will explore how the dysregulation of fundamental genetic and cellular processes contributes to the onset and progression of complex human diseases, with a focus on diseases of civilization. Contributions will cover basic molecular mechanisms, biomarker discovery, and translational perspectives across infectious, neurological, oncological, and metabolic disorders.

This Special Issue will fit within the journal’s scope by addressing key areas of cell biology, genetics, molecular medicine, and biomarker research. By gathering at least 10 high-quality contributions, this Special Issue will provide a comprehensive overview of this interdisciplinary field and may be printed in book form.

For this Special Issue, original research articles, short communications, and reviews are welcome. Research areas may include (but are not limited to) the following:

  • Mechanisms of cell division, cell cycle regulation, and systemic dysregulation;
  • Genetic and epigenetic regulation in health and disease;
  • Molecular biomarkers in cancer, infectious diseases, and neurodegeneration;
  • Cellular senescence, oxidative stress, and inflammation in chronic diseases and diseases of civilization;
  • Tumor microenvironment and cancer immunology;
  • Neuroinflammation, blood–brain barrier biology, and neurodegenerative disorders;
  • Multi-omics and single-cell approaches in biomarker discovery;
  • Translational research and clinical applications of genetic and molecular insights.

We look forward to receiving your contributions and creating a comprehensive resource that will advance our understanding of how cellular and genetic mechanisms drive systemic diseases.

Dr. Robert Zdanowski
Guest Editor

Dr. Agata Borkowska
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cell cycle regulation
  • genetic and epigenetic mechanisms
  • cellular senescence
  • oxidative stress
  • inflammation
  • molecular biomarkers
  • neurodegeneration
  • tumor microenvironment
  • metabolic and cardiovascular diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

25 pages, 1843 KB  
Review
Dual Roles of NIX/BNIP3L in Tumors: Friend or Foe
by Fanghui Ge, Jingxuan Shu, Ziqian Liu, Hong Zhang and Jiandong Wang
Biology 2026, 15(4), 302; https://doi.org/10.3390/biology15040302 - 9 Feb 2026
Viewed by 1020
Abstract
Cancer is one of the leading causes of disease-related death worldwide, and targeting key regulatory genes to induce programmed cell death in tumor cells has emerged as a crucial therapeutic strategy, following surgery, radiotherapy, and chemotherapy. As a mitochondrial outer membrane protein, NIX/BNIP3L [...] Read more.
Cancer is one of the leading causes of disease-related death worldwide, and targeting key regulatory genes to induce programmed cell death in tumor cells has emerged as a crucial therapeutic strategy, following surgery, radiotherapy, and chemotherapy. As a mitochondrial outer membrane protein, NIX/BNIP3L can both mediate apoptosis to inhibit tumor cell growth and promote tumor cell survival by clearing intracellular reactive oxygen species (ROS) through mitophagy. Therefore, we summarize a brief overview of the structure and function of NIX/BNIP3L, as well as the mechanisms of NIX/BNIP3L generation and degradation, the role of NIX/BNIP3L in mediating apoptosis and mitophagy and to advance the understanding of the roles of NIX/BNIP3L in glioblastoma, lung cancer, hepatocellular carcinoma, breast cancer, pancreatic cancer, colorectal cancer and hematologic neoplasms, aiming to enhance treatment precision and improve patient outcomes. Full article
Show Figures

Figure 1

Back to TopTop